DUBLIN--(BUSINESS WIRE)--The "Defibrillators Market by Product (Implantable Cardioverter Defibrillator (Transvenous ICD, Single & Dual Chamber, CRT-D, S-ICD), External (Manual, AED, Wearable)), End User (Hospitals, Pre-hospital, Public Access, Home care) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The global defibrillators market is projected to reach USD 11,784.4 million by 2025 from USD 9,652.2 million in 2019, at a CAGR of 3.4%.
Factors such as the rising prevalence of target diseases, growing focus on providing public-access defibrillators, and training & awareness programs on defibrillators are expected to propel the growth of this market. However, issues related to the use of implantable and automated external defibrillators and frequent product calls are expected to restrain the growth of the defibrillators market in the forecast period. The defibrillators market has witnessed significant developments in terms of technological advancements and new product developments.
The external defibrillators segment is expected to grow at the highest CAGR from 2019 to 2025
On the basis of products, the defibrillators market is classified into implantable cardioverter defibrillators (ICDs) and external defibrillators. The ICDs product segment is further segmented into transvenous implantable cardioverter defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillators (S-ICDs). The T-ICDs segment is further classified into single-chamber ICDs, dual-chamber ICDs, and cardiac resynchronization therapy defibrillators (CRT-Ds). The external defibrillators segment is further classified into external defibrillators, and wearable cardioverter defibrillators (WCDs). The external defibrillators segment is expected to grow at the highest CAGR in the forecast period, owing to factors such as the growing focus of key market players on developing easy-to-use defibrillators, increasing support from governments to install AEDs at public places, and rising adoption of WCDs.
The hospitals, clinics, and cardiac centers segment to dominate the global defibrillators market during the forecast period
On the basis of end-users, the defibrillators market is segmented into hospitals, clinics, and cardiac centers; pre-hospital care settings; public access markets; alternate care facilities; and home care settings. The hospitals, clinics, and cardiac centers segment is estimated to account for the largest share of the defibrillators market in 2019. A growing number of cardiac implant procedures across the globe and the availability of reimbursements across the developed markets are some of the major factors driving the growth of this segment.
APAC is projected to witness the highest growth during the forecast period
The Asia Pacific defibrillators market is expected to grow at the highest CAGR from 2019 to 2025. Factors such as the rapidly growing aging population, increasing cases of cardiovascular diseases, improving research infrastructure, and growing focus of key market players to expand their presence in this region are driving the growth of the Asia Pacific defibrillators market.
Market Dynamics
Drivers
- Rising Prevalence of Target Diseases
- Growing Focus on Providing Public-Access Defibrillators
- Training & Awareness Programs on Defibrillators
Restraints
- Issues Related to the Use of Implantable and Automated External Defibrillators
Opportunities
- Emerging Markets
- Development of S-Icds and Mri-Compatible Icds & Crt-Ds
Challenges
- Frequent Product Recalls
- Lack of Awareness About Sudden Cardiac Arrest in Developing Nations
Industry Trends
- Increasing Pricing Pressure on Market Players
- Growing Number of Mergers & Acquisitions Among Market Players
- Rising Demand for Automated External Defibrillators in Prehospital Settings
Regulatory Scenario
- External Defibrillators
-
Implantable Defibrillators
Company Profiles
- Biotronik
- Boston Scientific
- CU Medical Systems
- Koninklijke Philips N.V.
- Mediana
- Medtronic
- Metsis Medikal
- Microport
- Mindray Medical
- Nihon Kohden
- Physio-Control (Part of Stryker Corporation)
- Progetti Medical Equipment Solutions
- Schiller AG
- ST. Jude Medical (Acquired By Abbott Laboratories)
- Zoll Medical Corporation (A Part of Asahi Kasei Corporation)
For more information about this report visit https://www.researchandmarkets.com/r/abm1bw
